ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Ultomiris 300 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung - 
67278002 Alexion Pharma GmbH
Ultomiris 300 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung20.01.2020
  16.09.2021
Ravulizumab (L04AA43) 
WHO-DDD 
07.15. 
07.15. 
A  
Yes 
IP 
4035.61Yes
    
10 %4181.60
7680672780023Biotechnologika
  
Composition
ravulizumabum 300 mg, natrii dihydrogenophosphas, dinatrii phosphas, argininum, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 4.6 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Ravulizumabum300mg / 3ml
BAG: Active AgentDose
Ravulizumabum300 mg
 
Inactive agents
Arginine
Disodium Phosphate
Natrii Dihydrogenophosphas
Polysorbatum 80
Saccharum
 
Source
Data was imported : 05.09.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home